FINRA Loosens Broker Rules for Unregistered Securities Deals
Published Date: 9/30/2025
Notice
Summary
FINRA wants to update its Capital Acquisition Broker (CAB) rules to let brokers work with more types of investors and handle private securities deals more flexibly. These changes affect brokers, investors, and companies selling unregistered securities, aiming to make deals smoother and clearer. The SEC is reviewing the updates, with decisions expected soon, but no immediate money changes are announced.
Analyzed Economic Effects
2 provisions identified: 2 benefits, 0 costs, 0 mixed.
CABs Can Represent Investor Buyers
FINRA would let a Capital Acquisition Broker (CAB) represent either an issuer or an institutional investor buyer under proposed CAB Rule 016(c)(1)(F)(i) in sales of newly-issued, unregistered securities to institutional investors. If you run or own a privately-held company seeking institutional capital, CABs could now legally act for the buyers as well as the issuer in those private placements.
CABs May Represent Both Sides in M&A
FINRA would allow CABs to represent the buyer or the seller in a change-of-control transaction for a privately-held company and defines "control" as the power, directly or indirectly, to direct management or policies. Control is presumed if, upon completion of the transaction, the buyer or group of buyers will have the right to vote or the power to sell or direct the sale of 25% or more of a class of voting securities or (for partnerships/LLCs) has rights to 25% or more of capital.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-10373 — Registered Offering Reform
The SEC wants to make it easier and cheaper for more companies to sell their stocks and bonds to the public. They’re opening up special forms and benefits to more businesses, updating rules to be more modern, and cutting red tape by overriding some state rules. If you’re a company planning to raise money, these changes could speed things up and save you money, with feedback due by July 27, 2026.
2026-10222 — Enhancement of Emerging Growth Company Accommodations and Simplification of Filer Status for Reporting Companies
The SEC is making it easier for companies that report their finances by simplifying their categories into just two groups: big and small filers. Smaller companies, including emerging growth ones, will get more time to file reports and enjoy simpler rules, while big companies keep stricter standards. These changes aim to save time and money, with feedback open until July 20, 2026.
2026-07651 — Concept Release on Consolidated Audit Trail and Other Audit Trails and Data Sources
The SEC wants your thoughts on how it tracks stock market trades using the Consolidated Audit Trail and other data tools. They’re thinking about updating rules to keep up with new tech, privacy, and security needs, and to make sure the system is fair and cost-effective. If you’re involved in the stock market or data tracking, speak up by June 22, 2026!
2026-11919 — Self-Regulatory Organizations; MEMX LLC; Notice of Filing and Immediate Effectiveness of a Proposed Rule Change To Amend the Exchange's Fee Schedule Concerning Equities Transaction Pricing
MEMX is changing its fees starting June 1, 2026, by lowering some rebates for certain stock trades that add liquidity, especially for hidden and price-improved orders. These updates affect traders and members who use MEMX, meaning they might earn a bit less back on some trades. The goal? Keep things fair and balanced while keeping the exchange running smoothly.
2026-11927 — Self-Regulatory Organizations; MEMX LLC; Notice of Filing and Immediate Effectiveness of a Proposed Rule Change To Amend Rules 18.7 and 18.9 To Permit an Increase in Position and Exercise Limits for Options on IBIT
MEMX is raising the limits on how many options traders can hold and exercise for the iShares Bitcoin Trust ETF (IBIT). This change affects anyone trading IBIT options and lets them handle bigger positions starting right away. It’s designed to keep MEMX competitive and support growing market interest without any immediate cost impact.
2026-11922 — Self-Regulatory Organizations; Green Impact Exchange, LLC; Notice of Filing and Immediate Effectiveness of a Proposed Rule Change To Amend Rule 11.240 (Trade Reporting and Dissemination of Quotations) To Conform With Amendments to Rules 600 and 603 of Regulation NMS Approved by the Commission That Concern the Reporting and Dissemination of Odd-Lot Information, and an Additional Ministerial Change to Rule 11.220 To Correct a Typographical Error
Green Impact Exchange is updating its trade reporting rules to match new federal rules about sharing odd-lot trade info (small stock orders). They’re also fixing a tiny typo in another rule. These changes take effect right away and help keep trading info clear and accurate for everyone involved.
Previous / Next Documents
Previous: 2025-19052 — Self-Regulatory Organizations; Nasdaq ISE, LLC; Notice of Filing and Immediate Effectiveness of Proposed Rule Change To Amend NDX Fees
Starting October 1, 2025, Nasdaq ISE is updating the fees for trading Nasdaq 100 Index options (NDX) and their special expiration versions (NDXP). Traders and investors using these options will see new pricing rules that could affect their costs. These changes are effective immediately but officially kick in next month, so everyone should get ready for the new fee setup!
Next: 2025-19054 — David Payne, M.D.; Decision and Order
Dr. David Payne from California lost his DEA license to handle controlled substances because he’s no longer allowed to prescribe or participate in federal health programs. He didn’t ask for a hearing, so the DEA made the decision final. This means he can’t legally prescribe or manage controlled drugs starting now, impacting his medical practice and federal program involvement.